Table 3.
Comparison of baseline characteristics and clinical courses between SLR and non-SLR groups among NSCLC patients.
| Characteristics | SLR | No-SLR | P-value |
|---|---|---|---|
| Patient number | 8 | 79 | |
| Age, years | 68.6 ± 6.0 | 69.0 ± 6.1 | 0.877 |
| Male sex | 4 (50.0) | 39 (49.4) | >0.99 |
| Cell type | >0.99 | ||
| Adenocarcinoma | 7 (87.5) | 69 (87.3) | |
| Squamous cell carcinoma | 1 (12.5) | 10 (12.7) | |
| Treatment | >0.99 | ||
| Surgical resection | 7 (87.5) | 69 (87.3) | |
| Radiotherapy | 1 (12.5) | 10 (12.7) | |
| Chemotherapy | 0 (0.0) | 0 (0.0) | |
| Median follow-up period | 33.2 (11.6–64.8) | 18.5 (11.6–62.7) | 0.831 |
| Recurrence | 1 (12.5) | 11 (13.9) | >0.99 |
| Death | 0 (0.0) | 2 (2.5) | >0.99 |
| Disease-free survival, months | 26.3 (11.2–41.5) | 17.4 (10.3–38.0) | 0.814 |
Data are presented as means ± standard deviations, numbers (%), or as medians (interquartile range), unless otherwise indicated.
SLR, sarcoid-like reaction; NSCLC, non-small cell lung cancer.